Unknown

Dataset Information

Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?


ABSTRACT: The treatments available for thalassemia are rapidly evolving, with major advances made in gene therapy and the modulation of erythropoiesis. The latter includes the therapeutic potential of hepcidin tuning. In thalassemia, hepcidin is significantly depressed, and any rise in hepcidin function has a positive effect on both iron metabolism and erythropoiesis. Synthetic hepcidin and hepcidin mimetics have been developed to the stage of clinical trials. However, they have failed to produce an acceptable efficacy/safety profile. It seems difficult to avoid iron over-restricted erythropoiesis when directly using hepcidin as a drug. Indirect approaches, each one with their advantages and disadvantages, are many and in full development. The ideal approach is to target erythroferrone, the main inh

SUBMITTER: Longo F 

PROVIDER: S-EPMC9457499 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature